Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangmin Tong

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Oncotargets and Therapy|November 10, 2018
Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virusJiamin Peng, Shibing Wang, Weimin Fan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2018
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1Qiuran Xu, Qiaojuan Zhu, Zhenyu Zhou, et al.
Acta Biochimica Et Biophysica Sinica|April 6, 2015
Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cellsShuangshuang Li, Xiangli Gao, Xiaoxin Wu, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Review Article: Drug-Induced Liver Injury Associated With Antibody-Based Therapies in Haematologic MalignanciesMengmeng Lin, Yaping Xie, Jiahe Wu, et al.
International Journal of Oncology|March 10, 2023
UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinomaWen Fu, Xiangxiang Lei, Qiliang Lu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 24, 2025
Screening and treatment of thalassemiaYue Su, Jiahao Xie, Junjia He, et al.
Discover Oncology|September 27, 2024
Optimal cut-off values and diagnostic significance of clinical laboratory indicators in newly diagnosed multiple myelomaManning Li, Han Wu, Chunyi Shou, et al.
Current Treatment Options in Oncology|July 9, 2026
Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical ManagementMengmeng Lin, Shanshan Shi, Chong Zhang, et al.
Cancer Cell International|August 1, 2021
A review on the advances and challenges of immunotherapy for head and neck cancerGang Cheng, Hui Dong, Chen Yang, et al.
Oncology Reports|January 20, 2021
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivoShufang Xie, Weimin Fan, Chen Yang, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Oncotargets and Therapy|November 10, 2018
Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virusJiamin Peng, Shibing Wang, Weimin Fan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2018
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1Qiuran Xu, Qiaojuan Zhu, Zhenyu Zhou, et al.
Acta Biochimica Et Biophysica Sinica|April 6, 2015
Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cellsShuangshuang Li, Xiangli Gao, Xiaoxin Wu, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2025
Review Article: Drug-Induced Liver Injury Associated With Antibody-Based Therapies in Haematologic MalignanciesMengmeng Lin, Yaping Xie, Jiahe Wu, et al.
International Journal of Oncology|March 10, 2023
UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinomaWen Fu, Xiangxiang Lei, Qiliang Lu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 24, 2025
Screening and treatment of thalassemiaYue Su, Jiahao Xie, Junjia He, et al.
Discover Oncology|September 27, 2024
Optimal cut-off values and diagnostic significance of clinical laboratory indicators in newly diagnosed multiple myelomaManning Li, Han Wu, Chunyi Shou, et al.
Current Treatment Options in Oncology|July 9, 2026
Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical ManagementMengmeng Lin, Shanshan Shi, Chong Zhang, et al.
Cancer Cell International|August 1, 2021
A review on the advances and challenges of immunotherapy for head and neck cancerGang Cheng, Hui Dong, Chen Yang, et al.
Oncology Reports|January 20, 2021
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivoShufang Xie, Weimin Fan, Chen Yang, et al.
Pageof 13